Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 3/20 | 0.52 |
| ▸ | CTSS | P25774 | 6/20 | 0.51 |
| ▸ | CTSK | P43235 | 6/20 | 0.51 |
| ▸ | PPARA | Q07869 | 6/20 | 0.49 |
| ▸ | PPARG | P37231 | 5/20 | 0.49 |
| ▸ | CTSL | P07711 | 1/20 | 0.49 |
| ▸ | CTSB | P07858 | 1/20 | 0.49 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | PPARD | Q03181 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL47290 | 1.00 | TGFBR1 (0.52) | TGFBR1CTSSCTSKPPARAPPARG | |
| SCHEMBL47301 | 1.00 | TGFBR1 (0.52) | TGFBR1CTSSCTSKPPARAPPARG | |
| Water SCHEMBL23833041 | 0.98 | CTSS (0.54) | TGFBR1CTSSCTSKPPARAPPARG | |
| Ammonia Solution, Strong SCHEMBL28315164 | 0.98 | CTSK (0.50) | TGFBR1CTSSCTSKPPARAPPARG | |
| Water SCHEMBL31557653 | 0.98 | CTSS (0.54) | TGFBR1CTSSCTSKPPARAPPARG | |
| Propene SCHEMBL3265526 | 0.92 | CTSK (0.46) | TGFBR1CTSSCTSKPPARAPPARG | |
| SCHEMBL12980339 | 0.89 | CTSK (0.61) | TGFBR1CTSSCTSKPPARAPPARG | |
| SCHEMBL12980341 | 0.89 | CTSK (0.61) | TGFBR1CTSSCTSKPPARAPPARG | |
| Valine SCHEMBL5916993 | 0.87 | CA1 (0.45) | TGFBR1CTSSCTSKPPARAPPARG | |
| SCHEMBL29414393 | 0.87 | CTSS (0.46) | TGFBR1CTSSCTSKPPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1956 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119194649-B | Ultraviolet-resistant and moisture-absorbing fiber, preparation method thereof and fabric | 佛山市精度纺织有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-118988693-B | Preparation process of anti-pollution acrylic resin glass fiber sleeve | 东莞市好易达新材料科技有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-119241385-B | Beta-acyloxy enamide derivative and preparation method and application thereof | 江西师范大学 | 2025-03-25 | — | — | CN | claimed |
| CN-119241385-A | Beta-acyloxy enamide derivative and preparation method and application thereof | 江西师范大学 | 2025-01-03 | — | — | CN | claimed |
| CN-119194649-A | Ultraviolet-resistant and moisture-absorbing fiber, preparation method thereof and fabric | 佛山市精度纺织有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-119118877-A | Hydrophobic auxiliary material for assisting emulsification as well as synthesis method and application thereof | 浙江智达药业有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-118988693-A | Preparation process of anti-pollution acrylic resin glass fiber sleeve | 东莞市好易达新材料科技有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-118725577-A | Graphene heat-conducting rubber composite material for electric heating pad and preparation method | 威海毛纺织集团有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-118598771-A | Oral small molecule P-selectin inhibitor, and preparation method and application thereof | 首都医科大学 | 2024-09-06 | — | — | CN | claimed |
| CN-118324664-A | Serine derivative preparation method | 四川鸿日医药科技有限公司 | 2024-07-12 | — | — | CN | claimed |
| US-20050154211-A1 | Large scale synthesis of 1,2,4- and 1,3,4- oxadiazole carboxylates | KOLB HARTMUTH C (US) | 2005-07-14 | — | — | US | claimed |
| US-20040019215-A1 | Large scale synthesis of 1,2,4- and 1,3,4-oxadiazole carboxylates | LEXICON PHARMACEUTICALS, INC. | 2004-01-29 | — | — | US | claimed |
| US-20030083383-A1 | Method of using synthetic L-Se-methylselenocysteine as a nutriceutical and a method of its synthesis | SPALLHOLZ JULIAN E (US) | 2003-05-01 | — | — | US | claimed |
| US-6398857-B1 | ACCUSTIC PIEZOELECTRIC; HOT MELT INK JET PRINTING; BENZOIC ACID VEHICLE; ALKYL OR PHENYL CARBOXYLIC ACID VISCOSITY MODIFIER; RETAINS DESIRED HARDNESS | XEROX CORPORATION | 2002-06-04 | — | — | US | claimed |
| US-6395077-B1 | INKS WITH BENZOYLBENZOIC ACID AND COLORS | XEROX CORPORATION | 2002-05-28 | — | — | US | claimed |
| EP-1205471-A1 | A method of using synthetic L-SE-Methylselenocysteine as a nutriceutical and a method of its synthesis | PharmaSe, Incorporated (US) | 2002-05-15 | — | — | EP | claimed |
| US-5757408-A | PRINTING IMAGE ON SUBSTRATE COATED WITH AMINO-ACID DERIVATIVE ADDITIVE; QUICK DRYING OF INK, OPTICAL DENSITY, NONCURLING | XEROX CORPORATION (US) | 1998-05-26 | — | — | US | claimed |
| US-5683793-A | Ink jet transparencies | XEROX CORPORATION (US) | 1997-11-04 | — | — | US | claimed |
| US-5589277-A | INK JET PRINTING, AQUEOUS INKS, FAST DRYING | XEROX CORPORATION (US) | 1996-12-31 | — | — | US | claimed |
| EP-0667246-A1 | Recording sheets containing amino acids, hydroxy acids, and polycarboxyl compounds | XEROX CORPORATION (US) | 1995-08-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030083383-A1 | Method of using synthetic L-Se-methylselenocysteine as a nutriceutical and a method of its synthesis | SCLY, BHMT2, SELENOI | TGFBR1 2184/4885CTSS 3768/4885CTSK 4335/4885 |
| US-20050154211-A1 | Large scale synthesis of 1,2,4- and 1,3,4- oxadiazole carboxylates | OXA1L, ODC1, CYP4B1 | TGFBR1 4600/4885CTSS 2627/4885CTSK 2356/4885 |
| US-20040019215-A1 | Large scale synthesis of 1,2,4- and 1,3,4-oxadiazole carboxylates | OXA1L, ODC1, CYP4B1 | TGFBR1 4600/4885CTSS 2627/4885CTSK 2356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.